Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    

ALLERGAN, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ALLERGAN, INC.
2017Mylan defends chairman to ISS ahead of June 22 investor vote
RE
2017ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Soci..
PU
2017FEATURED COMPANY NEWS - MYLAN LAUNCH : Generic Reclast® Injection and Generic Az..
AQ
2017U.S. state, local government lawsuits over opioids face uphill battle
RE
2017ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 201..
PU
2017ALLERGAN PLC : Entry into a Material Definitive Agreement, Other Events, Financi..
AQ
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch R..
PU
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017HEALTH CANADA APPROVES ALLERGAN PLC : AGN) IBS Drug Viberzi
AQ
2017ALLERGAN : Eyepowerment™ Campaign Releases Survey Revealing the Importance..
PU
2017ALLERGAN : VIBERZI™ Now Approved in Canada for patients with irritable bow..
AQ
2017Several top fund managers trim Allergan stakes in first quarter
RE
2017CARL ICAHN : Icahn takes new 19.8 million share stake in Conduent in first quart..
RE
2017High-profile Snap stakeholders revealed in filings
RE
2017High-profile Snap stakeholders revealed in filings
RE
2017ALLERGAN, INC. : Today's Research Reports on Stocks to Watch: Allergan and Celge..
AC
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
2017Allergan posts loss as it writes down Teva holdings
RE
2017Allergan posts loss as it writes down Teva holdings
RE
2017Sanofi pegs U.S. drug price rises to below healthcare inflation
RE
2017ALLERGAN PLC (NYSE : AGN) reported earnings of $3.35 per share beating Walls Str..
AQ
2017ALLERGAN PLC (NYSE : AGN) Files An 8-K Results of Operations and Financial Condi..
AQ
2017ALLERGAN PLC : Results of Operations and Financial Condition, Financial Statemen..
AQ
2017ALLERGAN : tops Street 1Q forecasts, deal fuels guidance hike
AQ
2017ALLERGAN PLC (NYSE : AGN) Files An 8-K Submission of Matters to a Vote of Securi..
AQ
2017ALLERGAN PLC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2017ALLERGAN : to Present New Data at the 2017 American College of Obstetricians and..
PU
2017ALLERGAN : Successfully Completes ZELTIQ Aesthetics Acquisition
AQ
2017NOVARTIS : Allergan Expands Leading Research & Development NASH Program with Nov..
AQ
2017ALLERGAN : Granted Marketing Authorization by the FDA for TrueTear, the First In..
AQ
2017ALLERGAN : Novartis expands development programs for NASH through clinical colla..
AQ
2017ALLERGAN PLC (NYSE : AGN) Files An 8-K Other Events
AQ
2017ALLERGAN PLC : Other Events (form 8-K)
AQ
2017ALLERGAN : Exclusive New Interview Released with Allergan Global Regulatory Affa..
AQ
2017ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Millio..
PU
2017ALLERGAN : New Interview Released with Allergan Global Regulatory Affairs Direct..
AQ
2017ALLERGAN PLC ORDINARY SHARES’ : AGN) Initiative Creating Awareness to Peo..
AQ
2017ALLERGAN : Introducing Juvederm Vollure® at The Choe Center
AQ
2017Just Three of World's Top 28 Pharmaceutical Corporations Agree to Match Pledg..
AQ
2017ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to S..
PU
2017ALLERGAN : After iffy phase 2, Allergan plows forward with phase 3 Botox depress..
AQ
2017ALLERGAN : Teams Up With Media Mogul Wendy Williams to Debut the Patient Empower..
PU
2017ALLERGAN : acquires Zeltiq
AQ
2017ALLERGAN : To Test Botox For Depression Despite Mixed Results
AQ
2017IMPAX LABORATORIES : Board of Directors Appoints Paul M. Bisaro President and CE..
AQ
2017ALLERGAN : Center for Facial Rejuvenation's Cindy Wilson, NP Chosen as Official ..
AQ
2017ALLERGAN : exec Sanjiv Patel becomes new CEO at upstart Relay
AQ
2017ALLERGAN : Dr. Rubinstein Receives Allergan "Top 500" Award
AQ
2017ALLERGAN : FDA Approves Juvéderm Vollure XC for Laugh Lines, Notes Dr. F. Victor..
AQ
2017ALLERGAN : Dr. Justin Harper Selected for Allergans Facial Aesthetics National A..
AQ
2017ALLERGAN : Paratek hit late-stage acne goals, prep for sarecycline NDA
AQ
2017ALLERGAN, INC. : Blog Coverage Allergan and Paratek's Acne Drug Reported Positiv..
AC
2017ALLERGAN : Paratek Announce Positive Results from Two Phase 3 Trials for Moderat..
AQ
2017ALLERGAN : Dr. Justin Harper Selected for Allergan's Facial Aesthetics National ..
AQ
2017ALLERGAN : and Paratek Show Positive Results For Acne Treatment
AQ
2017PARATEK PHARMACEUTICALS, INC. (NASDA : PRTK) Files An 8-K Regulation FD Disclosu..
AQ
2017ALLERGAN : What Are Inversion Deals?
AQ
2017GLOBAL GLAUCOMA THERAPEUTICS MARKET : Allergan, Merck, Novartis, Pfizer, Santen..
AQ
2017GLOBAL GASTROINTESTINAL DRUGS MARKET : Abbott Laboratories, Allergan, AstraZenec..
AQ
2017Global Inhalation & Nasal Spray Generic Drugs Market- Teva, Allergan PLC, Cip..
AQ
2017ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Oph..
PU
2017ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Fac..
PU
2017ALLERGAN : Prevent Blindness and Allergan Work Together Through See America to P..
AQ
2017ALLERGAN : Editas partner on CRISPR tech in eye diseases
AQ
2017ALLERGAN : Lupin in fast lane with 5 launches in 15 days
AQ
2017ALLERGAN : Prevent Blindness and Allergan Work Together Through 'See America' to..
AQ
2017ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella for Lip Fullness And ..
AQ
2017ALLERGAN : celebrates commitment to KSA with new entity inaugural
AQ
2017ALLERGAN : Dr. Anil Shah MD, FACS Offers Juvederm Volbella® for Lip Fullness And..
AQ
2017EDITAS MEDICINE,INC. (NASDAQ : EDIT) Files An 8-K Entry into a Material Definiti..
AQ
2017Heptares adds Daiichi pain pact to string of R&D deals
AQ
2017ALLERGAN : Blindness treatment key to deal
AQ
2017ALLERGAN : Common explains why he's fighting against a blindness epidemic most p..
AQ
1  2  3  4  5  6  7  8  9  10Next
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
David Nakasone Investor Relations Contact
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.0
JOHNSON & JOHNSON-7.19%352 552
NOVARTIS-3.37%224 301
PFIZER-2.84%212 857
ROCHE HOLDING LTD.-9.37%210 327
MERCK AND COMPANY-0.50%149 572